<SEC-DOCUMENT>0001104659-22-072470-index.html : 20220617 <SEC-HEADER>0001104659-22-072470.hdr.sgml : 20220617 <ACCEPTANCE-DATETIME>20220617172038 ACCESSION NUMBER: 0001104659-22-072470 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20220810 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 221025109 BUSINESS ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>tm2217544-2_def14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: tm2217544-2_def14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>lg_vynethera-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: lg_vynethera-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>sg_daviddomzalskinew-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: sg_daviddomzalskinew-bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2217544d2-px_pg1vynethebw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2217544d2-px_pg1vynethebw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2217544d2-px_pg2vynethe4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2217544d2-px_pg2vynethe4c.jpg
</DOCUMENT> </SEC-DOCUMENT>